European evidence based consensus for endoscopy in inflammatory bowel disease
2013 · Journal of Crohn s and Colitis · 796 citations
https://doi.org/10.1016/j.crohns.2013.09.016
S
Shaji Sebastian
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
424
Papers
14.5K
Citations
55
h-index
132
i10-index
Shaji Sebastian is an academic researcher from Volgograd State Medical University. The author has contributed to research in topics: Inflammatory Bowel Disease & Microscopic Colitis & Eosinophilic Esophagitis. The author has an h-index of 55, co-authored 361 publications.
ORCID: 0000-0002-3670-6545Papers by this author
works3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 2: Surgical Management and Special Situations
2016 · Journal of Crohn s and Colitis · 745 citations
https://doi.org/10.1093/ecco-jcc/jjw169
HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn’s Disease
2019 · Gastroenterology · 400 citations
https://doi.org/10.1053/j.gastro.2019.09.041
Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial
2016 · The Lancet. Gastroenterology & hepatology · 253 citations
https://doi.org/10.1016/s2468-1253(16)30003-6
Natural Disease Course of Ulcerative Colitis During the First Five Years of Follow-up in a European Population-based Inception Cohort—An Epi-IBD Study
2018 · Journal of Crohn s and Colitis · 160 citations
https://doi.org/10.1093/ecco-jcc/jjy154
COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study
2022 · The Lancet. Gastroenterology & hepatology · 147 citations
https://doi.org/10.1016/s2468-1253(22)00005-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat